Eagle IP is Recognized in IP Stars 2022 in Patent Prosecution

September 2022

We are delighted to share that Eagle IP has been ranked in IP Stars 2022, from Managing IP, for our expertise in Patent Prosecution. Our President Dr. Jacqueline Lui is also ranked as a Patent Star 2022.

We are honored to be listed in this category among many other great firms in Hong Kong. We are thankful for Managing IP’s recognition of our deep expertise in US and China “cross-border” IP, our stellar life science team, and our strength in crafting and executing sophisticated and creative patent strategies.

Eagle IP is a top-tier boutique patent firm with a unique mix of experienced US and Chinese patent professionals with significant cross-border knowledge and experience. Our technically expertise covers wide range of technologies including, but not limited, to life sciences, biotechnology, medicine, and pharmaceuticals. We have years of experiences in drafting and prosecuting life sciences patent applications involving biological deposits, sequence listings, small and large molecules, drug discovery and development, and many others.

This article is for general informational purposes only and should not be considered legal advice or a legal opinion on a specific set of facts.